SunFire Biotechnologies

About:

SunFire Biotechnologies is a contract research organization formed by a group with extensive experience in pneumococcal vaccine evaluations.

Website: http://www.sunfirebio.com/

Top Investors: U.S. Department of Defense, Innovate Alabama

Description:

SunFire Biotechnologies is a contract research organization formed by a group with extensive experience in pneumococcal vaccine evaluations. SunFire offers testing for antibodies against the pneumococcal serotypes found in existing and developing pneumococcal vaccines, as well as for immunoassays for other bacterial species (such as GBS and Shigella).

Total Funding Amount:

$1M

Headquarters Location:

Birmingham, Alabama, United States

Founded Date:

2019-01-01

Founders:

Deborah J. Bidanset, Moon H. Nahm, Philip D Fernsten, Robert L. Burton, Tae Hea Nahm

Number of Employees:

1-10

Last Funding Date:

2022-08-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai